Updated On: 26 July, 2021 12:00 AM IST | New Delhi | PTI
Biological E is expected to apply for an Emergency use License (EUL) by August end and will be supplying 300 million doses to the Government of India by December 2021

Photo for representational purpose
The Hyderabad-based pharmaceutical company Biological E is expected to launch its Covid-19 vaccine Corbevax by September end in India, said sources on Monday.
Sources told ANI that the company has started its phase 3 clinical trials.